DrugDashboards

Ropivacaine hydrochloride

Ropivacaine hydrochloride · ROPIVACAINE HYDROCHLORIDE 1 kg/kg · Injection, Solution · Excella GmbH & Co. KG

NDC 46014-1058-00 · 50 kg in 1 DRUM · BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (bulk ingredient for human prescription compounding) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)Mar 27, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)Mar 27, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)Mar 23, 2018
    Demand increase for the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ropivacaine hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.ROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
SOLA Pharmaceuticals, LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi Usa, LlcROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Sagent PharmaceuticalsROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Excella GmbH & Co. KGROPIVACAINE HYDROCHLORIDE 1 kg/kgJul 15, 2026Aug 28, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ropivacaine hydrochloride — NDC 46014-1058-00," retrieved September 3, 2026, https://drugdashboards.com/drug/46014105800.

Free to cite with attribution — see how the data is put together.